- Lobbying
- genentech
Lobbying Arrangements Results for 'Genentech'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Antiviral stockpile for Pandemic, Tamiflu, 340B, 21st Century Cures, Appropriations. |
Genentech
|
CM GOVERNMENT RELATIONS | |||
Details GENERAL HEALTH CARE ISSUES, ISSUES RELATED TO FDA, PHARMACEUTICALS |
Genentech
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details CMS coding and coverage of a hemophilia drug |
Genentech
|
Krieg DeVault LLP | |||
Details Issues related to health care legislation. |
Genentech Inc.
|
Arnold & Porter Kaye Scholer LLP | |||
Details Medicare reimbursement for mobile strike units |
Genentech USA, Inc.
|
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | |||
Details Cancer Research Issues S. 3686/HR ____, Labor, Health, and Human Services Appropriations Bill for FY2011 |
Genentech, Inc.
|
Wheat Government Relations | |||
Details Health care and biotechnology legislation and regulations relating to FDA |
Genentech, Inc.
|
Liberty Partners Group, LLC | |||
Details Medicare Issues |
Genentech, Inc.
|
Kadesh & Associates, LLC | |||
Details Executive Order 13948 (Lowering Drug Prices by Putting America First) |
Genentech, Inc.
|
COVINGTON & BURLING LLP | |||
Details Tax reform, general corporate and international taxation |
Genentech, Inc.
Biotechnology |
Federal Policy Group, LLC | |||
Details APPROPRIATIONS HEALTH CARE REFORM |
GENENTECH
|
MCALLISTER & QUINN LLC | |||
Details Affordable Care Act Health Reform; Implementation of Health Reform; Medicare/Medicaid Reimbursement; Legislation for CMS. |
Genentech, Inc.
|
ALSTON & BIRD LLP | |||
Details Tax Reform Reimbursement Issues |
Genentech
|
The Franklin Partnership | |||
Details Advocacy related to health equity, diversity, and inclusion issues |
Genentech, Inc.
|
KING & SPALDING LLP | |||
Details S.___ Affordable Healthy Futures Act; America's Affordable Health Choices Act H.R.3200; Follow-on Biologics - H.R. 1427, H.R. 1548 |
Genentech, Inc.
|
FOLEY HOAG LLP | |||
Details General health care issues |
Farragut Partners on behalf of Genentech
|
WALTER CONSULTING | |||
Details Issues related to comprehensive tax reform and the tax treatment of foreign-owned U.S. corporations. Tax extender legislation, the Expiring Provisions Improvement Reform and Efficiency (EXPIRE) Act... |
Genentech, Inc.
Biotech industry. |
Squire Patton Boggs | |||
Details Policy issues related to Public Law 112-144, the Food and Drug Administration Safety and Innovation Act |
Genentech, Inc.
|
BAKER & HOSTETLER LLP | |||
Details Legislative and regulatory policies affecting biotechnology including: pharmaceutical development; biodefense; and diagnostics. H.R. 8295, Labor/HHS/Education Appropriations for FY2023, provisions ... |
Genentech USA, Inc.
|
DLA Piper LLP (US) | |||
Details Monitoring the implementation of the Patient Protection and Affordable Care Act, including provisions related to comparative effectiveness research and a regulatory pathway for biosimilars. Educate... |
Genentech, Inc.
|
W Strategies, LLC | |||
Details H.R. 3590 (Patient Protection and Affordable Care Act of 2010) |
Genentech
|
SIDLEY AUSTIN LLP | |||
Details Pricing, FDA and Medicare issues |
Genentech, Inc.
Biotechnology Research Company |
BARTLETT, BENDALL & KADESH, LLC | |||
Details Issues involving corporate taxation. |
Genentech
|
Eris Group (formerly known as Bartlett & Bendall) | |||
Details Ongoing Issues related to the implementation of the Affordable Care Act; H.R.6 - 21st Century Cures Act. |
Genentech
|
POLARIS GOVERNMENT RELATIONS, LLC | |||
Details Issues related to public health preparedness. Issues related to access to drugs for minority communities. Issues related to healthcare education and screening. Issues related to 340B Reform. Issues... |
Genentech Inc
|
OGR (formerly known as Ogilvy Government Relations) | |||
Details Policy and implementation issues relating to Public Law No. 111-148, the "Patient Protection and Affordable Care Act." Policy and implementation issues relating to Public Law No. 112-144, the "Food... |
Genentech, Inc.
Biotechnology research and manufacturer. |
Ferguson Strategies, LLC | |||
Details Intellectual Property and Process Patent Issues-Patent Reform Act (all provisions). Implementation of P.L. 108-173, matters related to Medicare and Medicaid Coverage and Reimbursement [Medicare Pre... |
Cauthen Forbes & Williams on behalf of Genentech
|
Forbes-Tate | |||
Details Issues related to pandemic preparedness and macular degeneration. Issues related to health care reform. |
Genentech Inc. (formerly known as Hoffman-La Roche)
|
Ice Miller Strategies LLC | |||
Details Issues related to health care, the Food and Drug Administration (FDA), drug pricing and the 340b program. HR 878, Trickett Wendler Right to Try Act of 2017/S. 204, Trickett Wendler, Frank Mongiell... |
Genentech
|
Missy Edwards Strategies, LLC | |||
Details General Information Meetings. |
Genentech
Biotechnology Firm |
The Normandy Group, LLC | |||
Details Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169). Issues related to the HHS Notice of Benefit and Payment Pa... |
Genentech, Inc.
|
Tiber Creek Health Strategies, Inc. | |||
Details H.R. 3962, Affordable Health Care for America Act; health disparities and diabetes awareness |
Hoffman-La Roche, Inc.
|
CLYBURN CONSULTING, LLC | |||
Details HCR -Issues related to healthcare legislation, drug pricing generally including and the 340B Drug Discount Program; issues and policies relating to the FDA including biopharmaceutical development a... |
Genentech
|
Rivendell Group LLP | |||
Details Educating Members of Congress and their staffs about market-based health policy |
Genentech, Inc.
Biotech Company |
Quinn Gillespie & Associates | |||
Details Consulting on Legislation & Public policy related to the pharmaceutical industry. |
S&B Public Solutions, LLC DBA Hilltop Public Solutions on behalf of Genentech
Pharmaceutical |
McBee Strategic Consulting, LLC | |||
Details Reforms to the MACRA statute. |
MACRA Alliance
|
Leavitt Partners, LLC | |||
Details Provide guidance and strategic counsel with regard to regulations and legislation that could impact, pharmaceutical and biotechnology manufacturers. |
Genentech, Inc.
|
BGR Government Affairs | |||
Details Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169); Issues relating to Medicare Part B Pricing Re... |
Tiber Creek Health Strategies, Inc. (On behalf of Genentech, Inc.)
|
Tiber Creek Group | |||
Details FY15 Labor, HHS and Education Appropriation related to preparedness for pandemic influenza, HIV/AIDS programs, hepatitis screening, care and treatment, and access to breast cancer treatment. Legisl... |
GENENTECH, INC. (FORMERLY KNOWN AS HOFFMAN-LA ROCHE, INC)
|
WINNING STRATEGIES WASHINGTON | |||
Details Appropriations relating to influenza |
Genentech, Inc.
|
Cornerstone Government Affairs, Inc. | |||
Details Issues related to Inflation Reduction Act of 2022 (PL 117-169) implementation; Issues related to Medicare Part B, CMS coverage and reimbursement; Issues related to insulin out of pocket costs; S... |
Genentech USA, Inc.
|
Avenue Solutions | |||
Details Issues related to FDA and HHS program funding in the FY20 Labor, Health and Human Services, and Education and Related Agencies, and FY20 Agriculture, Rural Developments, Food and Drug Administratio... |
Genentech
|
S-3 Group | |||
Details Intellectual Property and Process Patent Issues HR 1908, Patent Reform Act (all provisions). Implementation of P.L. 108-173, matters related to Medicare and Medicaid Coverage and Reimbursement [Med... |
Genentech
|
CAUTHEN FORBES & WILLIAMS | |||
Details Medicare and Medicaid payment issues. 340B. Implementation of Inflation Reduction Act of 2022. Prescription drug payment reform. Supply chain. Strategic National Stockpile. 340B. Pandemic and All-H... |
Genentech, Inc.
|
Todd Strategy Group | |||
Details General IP Issues. Patent Litigation Reform. Trade Negotiations. Trade Policy Issues. Drug Pricing Issues. Public Health Crisis. H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security Act o... |
Genentech, Inc.
|
AMERICAN CONTINENTAL GROUP | |||
Details Access and reimbursement in Medicare Parts B and D. Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. S. 2764/H.R.5391 - Protecting Patient Ac... |
GENENTECH
|
THE MCMANUS GROUP | |||
Details Issues related to public health preparedness; Issues related to access to drugs for minority communities; Issues related to healthcare education and screening. Issues regarding waiver of intellectu... |
Genentech Inc
|
AKIN GUMP STRAUSS HAUER & FELD | |||
Details Implementation of PPACA. Patent Reform Act of 2009. |
GENENTECH, INC
|
DUTKO WORLDWIDE, LLC | |||
Details Improvements to the 340B drug discount program. |
340B Working Table
|
Leavitt Partners, LLC | |||
Details Issues regarding Medicare payment policies for Part B drugs. Issues related to the 340B Drug discount program. Drug Pricing Proposals. CMMI Guardrails. Issues related to drug pricing (IPI, Part B r... |
Genentech
|
Farragut Partners LLP |